Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Venue 22
About the venue
Rooms
Call for abstracts
Programme 22
Tracks 22
Speakers 22
Side events 22
Subscribe
days
hours
minutes
seconds
User perspectives
Sessions
Thursday, 24 November
13:20
Diversity, stigma, and vulnerability
13:20
to
14:50
Networking zone 4 (N4)
Short communication session
15:00
Client-centered approaches
15:00
to
16:30
Central square 3 (C3)
Oral presentation session
Drug deaths: A social, structural and systems analysis
15:00
to
16:30
Knowledge market 1 (K1)
Structured session
16:50
Informing and delivering treatment
16:50
to
18:20
Networking zone 3 (N3)
Short communication session
Insights from treatment I
16:50
to
18:20
Central square 3 (C3)
Oral presentation session
Prison and drugs: exploring social determinants and pathways to drug problem and incarceration
16:50
to
18:20
Central square 1 (C1)
Structured session
Friday, 25 November
10:50
A Digital Future? Engaging online communities of people who use drugs to influence policy and practice
10:50
to
12:20
Central square 4 (C4)
Workshop
13:20
Navigating the future of supervised consumption research and intervention: European and North American experiences
13:20
to
14:50
Central square 2 (C2)
Structured session
The experience of persons in homeless situation with alcohol related problems regarding a pharmacological harm reduction initiative
13:20
to
14:50
Knowledge market 4 (K4)
Structured session
Working with the most vulnerable
13:20
to
14:50
Central square 3 (C3)
Oral presentation session
Presentations
Thursday, 24 November
13:20
Short communication
SHIFT + Parent Training - An Intervention for Mothers and Fathers Using Illicit Drugs'
13:20
to
14:50
Networking zone 4 (N4)
Diana Moesgen
Short communication
Perceptions of prospective pharmaceutical stimulant substitution treatments among people who use illicit stimulants in Vancouver, Canada
13:20
to
14:50
Networking zone 4 (N4)
Taylor Fleming
Short communication
Trends and factors associated with illicit drug use and HIV outcomes in South Africa: findings from multiple national population-based household surveys
13:20
to
14:50
Networking zone 4 (N4)
Kennedy Kipkoech
Short communication
Perceived Impact of Storytelling on Substance Use Self-Stigma
13:20
to
14:50
Networking zone 4 (N4)
Glenn Sterner
Short communication
Social attitudes towards drug users in the context of perceptions of other marginalised social groups, based on the NSAPH 2019 Survey
13:20
to
14:50
Networking zone 4 (N4)
Katalin Felvinczi
Short communication
Cannabis engagement in Riga, Latvia: Voices from impacted communities
13:20
to
14:50
Networking zone 4 (N4)
Kristiana Bebre
Short communication
Under-reporting of meth/amphetamine use in Australia following negative media coverage
13:20
to
14:50
Networking zone 4 (N4)
Daniel Stjepanovic
Short communication
Treatment of drug use disorders in Central Asia, China, and Germany – what is the state of the art?
13:20
to
14:50
Networking zone 4 (N4)
Ingo Ilja Michels
15:00
Oral presentation
5. Drug Policy and The Rise and Decline of Racial Stratification of Prescribing and Overdose Mortality
15:00
to
16:30
Knowledge market 1 (K1)
Brian Kelly
Oral presentation
1. Drug-related deaths among young people: a social, structural and systems autopsy
15:00
to
16:30
Knowledge market 1 (K1)
Aileen O'Gorman
Oral presentation
2. Drug-related deaths in prisons in England and Wales, 2015-2020: an examination of key trends and issues for policy and practice
15:00
to
16:30
Knowledge market 1 (K1)
Karen Duke
Oral presentation
3. The role of Primary Care in the prevention of drug-related deaths: Patient and family member perspectives
15:00
to
16:30
Knowledge market 1 (K1)
Katie Colliver
Discussion
What can a social, structural and systems analysis tell us about drug-related deaths and what are the implications for policy and addiction science?
15:00
to
16:30
Knowledge market 1 (K1)
Anne Whittaker
Oral presentation
4. The role of Primary Care in the prevention of drug-related deaths: service provider perspectives
15:00
to
16:30
Knowledge market 1 (K1)
Betsy Thom
Oral presentation
Who is using take-home naloxone? An examination of super-savers
15:00
to
16:30
Central square 3 (C3)
Desiree Eide
Oral presentation
Examining health care from the drug user perspective: what works, what doesn't and what needs to change
15:00
to
16:30
Central square 3 (C3)
Mary Ellen Harrod
Oral presentation
An Evaluation of the Co-Design of an Anti-Stigma Training Programme
15:00
to
16:30
Central square 3 (C3)
Sonam Prakashini Banka
Oral presentation
Once you’ve addressed your drinking, we’ll address your mental health': A qualitative exploration of patient and providers’ experiences of services for co-occurring heavy drinking and depression in North East England
15:00
to
16:30
Central square 3 (C3)
Amy O'Donnell
Oral presentation
Police officers’ attitudes and practices toward harm reduction services in Sweden – a qualitative study
15:00
to
16:30
Central square 3 (C3)
Johan Nordgren
16:50
Oral presentation
The acceptability and feasibility of implementing and evaluating the Parents under Pressure (PuP) parenting programme with opioid-dependent fathers and their families: results from the PuP4Dads study.
16:50
to
18:20
Central square 3 (C3)
Anne Whittaker
Short communication
The Treatment of Addictions in Portugal - What Future?
16:50
to
18:20
Networking zone 3 (N3)
João Feliz
Short communication
The effect of opioid agonist therapy on mental health of PWID in Ukraine
16:50
to
18:20
Networking zone 3 (N3)
Iryna Ivanchuk
Oral presentation
Ayahuasca-assisted addiction treatment in Peru: qualitative results from a multi-year, mixed-methods study
16:50
to
18:20
Central square 3 (C3)
Olivia Marcus
Oral presentation
EXtended-release Pharmacotherapy for Opioid Use Disorder (EXPO)
16:50
to
18:20
Central square 3 (C3)
John Marsden
Oral presentation
Characteristics of concerned persons (CPs) accessing treatment services in their own right: A secondary analysis of Irish health data for 2010-2020.
16:50
to
18:20
Central square 3 (C3)
Cathy Kelleher
Short communication
Outreach for socially marginalized trimorbid veterans in Denmark – preliminary results
16:50
to
18:20
Networking zone 3 (N3)
Henrik Thiesen
Short communication
A Feasibility Study of Mentalization Based Therapy for Antisocial personality disorder with substance use disorder in Norway- preliminary findings
16:50
to
18:20
Networking zone 3 (N3)
Katharina Morken
Short communication
Working in drug treatment and health care facilities
16:50
to
18:20
Networking zone 3 (N3)
Maitena Milhet
Short communication
Incidence and determinants of CoVID-19 in patients seeking treatment of Substance Use Disorder: a population-based linkage study
16:50
to
18:20
Networking zone 3 (N3)
Irene Lana
Short communication
Perspectives Pathways and Priorities of People with Lived and Living Experience of Substance Use: Informing Policies (P5 Project YXE)
16:50
to
18:20
Networking zone 3 (N3)
Barbara Fornssler
Oral presentation
2. Characteristics associated with drug use during the current detention – results from prison surveys in 4 EU countriessurveys in 4 EU countries
16:50
to
18:20
Central square 1 (C1)
Els Plettinckx
Oral presentation
5. Social determinants, health service contacts and incarceration among all those dying from an accidental overdose 2010-2018 in Norway
16:50
to
18:20
Central square 1 (C1)
Ellen J. Amundsen
Oral presentation
3. Reimprisonment rates among men who inject drugs in Victoria, Australia
16:50
to
18:20
Central square 1 (C1)
Ashleigh C. Stewart
Oral presentation
4. Adverse childhood experiences, substance use, and involvement with correctional services
16:50
to
18:20
Central square 1 (C1)
Richard Pates
Oral presentation
6. Wasted': the complex trajectories from incarceration to recovery. A personal experience
16:50
to
18:20
Central square 1 (C1)
Mark Johnson Ferguson
Discussion
Common pathways to problematic drug use and incarceration and lessons learnt for policy and practice
16:50
to
18:20
Central square 1 (C1)
Liesbeth Vandam
Oral presentation
1. Use pathways in prison. A French literature review
16:50
to
18:20
Central square 1 (C1)
Caroline Protais
Friday, 25 November
10:50
Oral presentation
European Web Survey on Drugs
10:50
to
12:20
Central square 4 (C4)
João Matias,
José Pedro Teixeira
Oral presentation
European Web Survey on Drugs - Luxembourg
10:50
to
12:20
Central square 4 (C4)
Rita Cardoso Seixas
Oral presentation
European Web Survey on Drugs - Ireland
10:50
to
12:20
Central square 4 (C4)
Nicki Killeen
Oral presentation
The experience of running web surveys in Belgium
10:50
to
12:20
Central square 4 (C4)
Elena Damian
Oral presentation
Web surveys on drugs - how can these be important for those who use drugs
10:50
to
12:20
Central square 4 (C4)
Lígia Parodi
13:20
Oral presentation
Psychosocial functions of drug using and selling among young persons in Malmö who came to Sweden as unaccompanied refugee minors
13:20
to
14:50
Central square 3 (C3)
Anke Stallwitz
Oral presentation
Re-visioning from risk and safety to survival and wellness; behaviours among people who use methamphetamine with opioids in British Columbia, Canada
13:20
to
14:50
Central square 3 (C3)
Jessica Xavier
Oral presentation
Indigenous Peoples experiences with overdose and response in Vancouver, Canada's Downtown Eastside
13:20
to
14:50
Central square 3 (C3)
Jennifer Lavalley
Oral presentation
Watch out for the boogieman': multiple stigma and recovery experiences of ethnic minorities with substance use problems
13:20
to
14:50
Central square 3 (C3)
Aline Pouille
Oral presentation
3. Navigating an emergency response and collective action on the fentanyl frontlines: An ethnographic study of overdose prevention site implementation in Vancouver, Canada’s Downtown Eastside
13:20
to
14:50
Central square 2 (C2)
Ryan McNeil
Oral presentation
1. Drug consumption rooms: welfare state and social acceptance in France
13:20
to
14:50
Central square 2 (C2)
Marie Jauffret-Roustide
Oral presentation
2. Drug consumption rooms in Denmark: attitudes and experiences from local residents
13:20
to
14:50
Central square 2 (C2)
Esben Houborg
Oral presentation
4. More than overdose prevention: (Re)evaluating gender-attentive supervised consumption services
13:20
to
14:50
Central square 2 (C2)
Jade Boyd
Oral presentation
Prevention and Treatment of hazardous Substance Use among Refugees: Perspectives from Germany
13:20
to
14:50
Central square 3 (C3)
Marion Laging
Oral presentation
2. The experience of persons in homeless situation with alcohol related problems regarding a pharmacological harm reduction initiative
13:20
to
14:50
Knowledge market 4 (K4)
Raquel Medinas
Oral presentation
4. The role of those without a role - The perspective of non-clinical professionals in emergencyshelters on how to manage alcohol use disorder - police, security agents and cleaning staff
13:20
to
14:50
Knowledge market 4 (K4)
Ricardo Fuertes
Oral presentation
3. Amidst the most vulnerable voices: women and migrants in homeless situation with Alcohol UseDisorders (AUD)
13:20
to
14:50
Knowledge market 4 (K4)
Màrio Santos
Oral presentation
5. All we can do - Emergency Shelter' staff positioning regarding alcohol related problems in thecontext of a new harm reduction intervention
13:20
to
14:50
Knowledge market 4 (K4)
Joana Tavares
Oral presentation
1. Individuals with lived experience of homelessness and alcohol use disorders - insights from the PLACE study
13:20
to
14:50
Knowledge market 4 (K4)
Ana Neto